Santé News

January 24, 2018

Marlborough, MA
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 22, 2018

San Francisco, CA
Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)

October 23, 2017

Santa Rosa, CA
Claret Medical Closes $14.5 Million in Series C Financing to Extend Successful U.S. Launch of Sentinel Cerebral Protection System

August 2, 2017

Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements

June 16, 2017

Sentinel Cerebral Protection System Used Commercially by TAVR Centers of Excellence Nationwide

June 15, 2017

TVA Medical – Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology

June 14, 2017

BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART™ 300 Aortic Annuloplasty Device

June 5, 2017

Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

May 12, 2017

Millipede Announces Successful First Use of the Iris Complete Annuloplasty Ring

March 24, 2017

Biostable Science & Engineering scores FDA nod for aortic valve repair device

March 17, 2017

Austin, TX
Threshold Pharmaceuticals and Molecular Templates Agree to Combine

March 6, 2017

FDA Advisory Committee Strongly Supports Granting De Novo Application for Claret TAVR Cerebral Protection System

February 1, 2017

TVA Medical – Everlinq Endoavf System as a viable alternative to surgical AVF procedures

October 28, 2016

New data on EndoStim® therapy for the treatment of gastro-esophageal reflux disease (GERD) presented at United European Gastroenterology Week 2016

September 20, 2016

Santa Rosa, CA
Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference